The first option has for instance been explored by targeting B cells in gMG, RA (NCT00931086), ITP, CIDP, Sjgrens syndrome (NCT03154385, NCT02531538, NCT03905525), and TED (NCT00212726) [383, 384] with therapeutic mAbs directed against CD20, B-lymphocyte stimulator protein, and CD40
Zeel Zeel injections are used to support the treatment of bone fractures, slow-healing bones, and bone pain by promoting tissue regeneration and reducing inflammation
pilot study (BMC Gastroenterol, 2017, PMC5548760) found that 300 mg/day oral glutathione for 4 months reduced ALT and liver fat markers in 29 NAFLD patients
This leads to whats called higher bioavailability, meaning a greater percentage of the dose reaches the target tissues